Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;9(4):2518-2526.
doi: 10.21037/tcr.2020.03.04.

Prognosis value of liver stiffness measurements by 2D-SWE in primary HBV-positive hepatocellular carcinoma following radiofrequency ablation

Affiliations

Prognosis value of liver stiffness measurements by 2D-SWE in primary HBV-positive hepatocellular carcinoma following radiofrequency ablation

Xinxin Xie et al. Transl Cancer Res. 2020 Apr.

Abstract

Background: Liver fibrosis is closely associated with the occurrence of hepatocellular carcinoma (HCC), which can be evaluated by liver stiffness measurements (LSM). The clinical significance of LSMin patient with hepatitis B virus (HBV) related HCC underwent radiofrequency ablation (RFA) was evaluated.

Methods: Total of 273 patients underwent RFA for primary HBV-positive HCC were included. LSM values were measured by using by 2D-shear wave elastography (2D-SWE) prior to RFA. The relationship between pretreatment LSM value and survival outcome was evaluated. The cutoff value for LSM to predict survival outcome was determined by receiver operating characteristic (ROC) curve analysis.

Results: At the endpoint of this study, 88 (32.2%) and 73 (26.7%) patients out of all 273 patients studied had died and recurrent, respectively. All patients were divided into two groups based on the cutoff value (13.4 kPa) of LSM. Patients with a LSM ≥13.4 kPa had lower mean overall survival (62.5 vs. 48.5 months, P=0.01) and lower recurrent free survival (60.4 vs. 47.3 months, P=0.02) than patients with a LSM <13.4 kPa in univariate analysis and LSM also been evaluated as independent predictive factor for survival outcome for HCC following RFA. Otherwise, LSM also was related to liver cirrhosis and TNM stage (both P<0.05).

Conclusions: LSM measured by 2D-SWE can sever as an independent prognostic indictor for patients undergoing RFA for HBV-positive HCC.

Keywords: Liver stiffness; hepatitis B virus (HBV); hepatocellular carcinoma (HCC); prognosis; radiofrequency ablation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure from (available at http://dx.doi.org/10.21037/tcr.2020.03.04). Both authors have no conflicts of interests to declare.

Figures

Figure 1
Figure 1
Receiver-operator characteristic curve for LSM measured by 2D-SWE. the AUC were 0.81 with a 95% CI between 0.70 and 0.92, P<0.01.
Figure 2
Figure 2
Kaplan–Meier estimates of survival. (A) Patients with a high LSM level had a poorer OS than those with a low LSM level (62.5 vs. 48.5 months, P=0.01). (B) Patients with a high LSM level had a poorer OS than those with a low LSM level (60.4 vs. 47.3 months, P=0.02).

References

    1. Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond) 2019;39:22. 10.1186/s40880-019-0368-6 - DOI - PMC - PubMed
    1. Parikh ND, Fu S, Rao H, et al. Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA. Dig Dis Sci 2017;62:3243-53. 10.1007/s10620-017-4776-7 - DOI - PubMed
    1. Niu J, Lin Y, Guo Z, et al. The Epidemiological Investigation on the Risk Factors of Hepatocellular Carcinoma: A Case-Control Study in Southeast China. Medicine (Baltimore) 2016;95:e2758. 10.1097/MD.0000000000002758 - DOI - PMC - PubMed
    1. Du XF, Zhang LL, Zhang DZ, et al. Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer. Onco Targets Ther 2018;11:6767-75. 10.2147/OTT.S153946 - DOI - PMC - PubMed
    1. Poon RT. Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge. Hepatology 2011;54:757-9. 10.1002/hep.24569 - DOI - PubMed